Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential.
- DOI
- 10.1016/j.biopha.2021.112230
- Published
- 2021-10-06
- Container
- Biomed Pharmacother
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2021.112230,
title = {Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential.},
author = {Kamyshnyi O and Matskevych V and Lenchuk T and Strilbytska O and Storey K and Lushchak O.},
year = {2021},
journal = {Biomed Pharmacother},
doi = {10.1016/j.biopha.2021.112230},
url = {https://doi.org/10.1016/j.biopha.2021.112230}
}RIS
TY - JOUR TI - Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential. AU - Kamyshnyi O AU - Matskevych V AU - Lenchuk T AU - Strilbytska O AU - Storey K AU - Lushchak O. PY - 2021 JO - Biomed Pharmacother DO - 10.1016/j.biopha.2021.112230 UR - https://doi.org/10.1016/j.biopha.2021.112230 ER -
APA
O, K., V, M., T, L., O, S., K, S., & O., L. (2021). Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential.. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2021.112230
Source records
- europe-pmc · retrieved 2026-09-27T11:12:58.263Z